Suchergebnisse - (Subject:"O3J8G9O825")

PubPharm (5.515)

81

Studies Investigate Whether Antivirals Like Paxlovid May Prevent Long COVID

enthalten in: JAMA | 2024

von Suran, M.

82

Clinical efficacy of nirmatrelvir plus ritonavir in patients with COVID-19 and preexisting cardiovascular diseases

enthalten in: Expert review of anti-infective therapy | 2024

von Liu, T. | Wu, J. | Huang, P. | +5

83

Real-world effectiveness of nirmatrelvir-ritonavir versus azvudine in hospitalized patients with COVID-19 during the omicron wave in Beijing : a multicenter retrospective cohort study

enthalten in: BMC infectious diseases | 2024

von Han, X. | Gao, D. | Li, C. | +18

84

PBPK Modeling of PAXLOVIDTM : Incorporating Rotamer Conversion Kinetics to Advanced Dissolution and Absorption Model

enthalten in: Journal of pharmaceutical sciences | 2024

von Jaini, R. | Lin, J. | Di, L. | +1

85

Pharmacokinetics and tolerability of the maturation inhibitor GSK3640254 coadministered with darunavir/ritonavir and/or etravirine in healthy adults

enthalten in: British journal of clinical pharmacology | 2024

von Zhang, Y. | Joshi, S. | Yazdani, P. | +6

86

A Comprehensive Review of the Clinical Pharmacokinetics, Pharmacodynamics, and Drug Interactions of Nirmatrelvir/Ritonavir

enthalten in: Clinical pharmacokinetics | 2024

von Gerhart, J. | Cox, D. | Singh, R. | +6

87

Effectiveness and safety of azvudine in older adults with mild and moderate COVID-19 : a retrospective observational study

enthalten in: BMC infectious diseases | 2024

von Zhou, Z. | Zheng, H. | Xiao, G. | +3

88

Azvudine versus paxlovid for oral treatment of COVID-19 in Chinese patients

enthalten in: BMC infectious diseases | 2024

von Su, P. | Yang, C. | Wang, X.

89

Factors associated with the acceptability of Lopinavir/Ritonavir formulations among children living with HIV/AIDS attending care and treatment clinics in Mbeya and Mwanza, Tanzania

enthalten in: PloS one | 2024

von Jiwa, N. | Ketang'enyi, E. | Nganyanyuka, K. | +12

90

Adverse Events of SARS-CoV-2 Therapy : A Pharmacovigilance Study of the FAERS Database

enthalten in: The Annals of pharmacotherapy | 2024

von Pannu, V. | Udongwo, N. | Imburgio, S. | +10